1. Home
  2. ANVS vs MBBC Comparison

ANVS vs MBBC Comparison

Compare ANVS & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • MBBC
  • Stock Information
  • Founded
  • ANVS 2008
  • MBBC 1902
  • Country
  • ANVS United States
  • MBBC United States
  • Employees
  • ANVS N/A
  • MBBC N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • MBBC Banks
  • Sector
  • ANVS Health Care
  • MBBC Finance
  • Exchange
  • ANVS Nasdaq
  • MBBC Nasdaq
  • Market Cap
  • ANVS 24.2M
  • MBBC 22.1M
  • IPO Year
  • ANVS 2020
  • MBBC N/A
  • Fundamental
  • Price
  • ANVS $1.53
  • MBBC $10.05
  • Analyst Decision
  • ANVS Strong Buy
  • MBBC
  • Analyst Count
  • ANVS 4
  • MBBC 0
  • Target Price
  • ANVS $40.67
  • MBBC N/A
  • AVG Volume (30 Days)
  • ANVS 460.8K
  • MBBC 13.3K
  • Earning Date
  • ANVS 05-20-2025
  • MBBC 05-12-2025
  • Dividend Yield
  • ANVS N/A
  • MBBC N/A
  • EPS Growth
  • ANVS N/A
  • MBBC N/A
  • EPS
  • ANVS N/A
  • MBBC N/A
  • Revenue
  • ANVS N/A
  • MBBC $6,554,694.00
  • Revenue This Year
  • ANVS N/A
  • MBBC N/A
  • Revenue Next Year
  • ANVS N/A
  • MBBC N/A
  • P/E Ratio
  • ANVS N/A
  • MBBC N/A
  • Revenue Growth
  • ANVS N/A
  • MBBC N/A
  • 52 Week Low
  • ANVS $1.11
  • MBBC $5.83
  • 52 Week High
  • ANVS $17.88
  • MBBC $12.00
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 49.17
  • MBBC N/A
  • Support Level
  • ANVS $1.42
  • MBBC N/A
  • Resistance Level
  • ANVS $1.75
  • MBBC N/A
  • Average True Range (ATR)
  • ANVS 0.16
  • MBBC 0.00
  • MACD
  • ANVS 0.03
  • MBBC 0.00
  • Stochastic Oscillator
  • ANVS 43.59
  • MBBC 0.00

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Share on Social Networks: